Instrument Inactif

Communiqués Allos Therapeutics, Inc.

Actions

US0197771019

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Allos Therapeutics, Inc. : Spectrum Pharmaceuticals and Allos Therapeutics Announce Expiration of Offering Period and Final Completion of Tender Offer for Shares of Allos Therapeutics	05/09/12	BU
Allos Therapeutics, Inc. : Spectrum Pharmaceuticals and Allos Therapeutics Announce That FTC Clears Transaction; Tender Offer for Shares of Allos Common Stock To Expire at 5pm Eastern Time on September 4, 2012	29/08/12	BU
Allos Therapeutics, Inc. : Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics	17/08/12	BU
Allos Therapeutics, Inc. : Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics	04/08/12	BU
Allos Therapeutics, Inc. : Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics	20/07/12	BU
Allos Therapeutics, Inc. : Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics	07/07/12	BU
Allos Therapeutics, Inc. : Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics	22/06/12	BU
Allos Therapeutics, Inc. : Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics	08/06/12	BU
Allos Therapeutics, Inc. : Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics	25/05/12	BU
Allos Therapeutics, Inc. : Spectrum Pharmaceuticals and Allos Therapeutics Announce Extension of Previously Announced Tender Offer For Shares of Allos Therapeutics	10/05/12	BU
Allos Therapeutics, Inc. : Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Allos Therapeutics, Inc.	02/05/12	BU
Allos Therapeutics, Inc. : Allos Therapeutics Announces Outcome of Request for Re-examination of CHMP Opinion for FOLOTYN(R) in Europe	20/04/12	PU
Allos Therapeutics, Inc. : Allos Therapeutics Announces Outcome of Request for Re-examination of CHMP Opinion for FOLOTYN® in Europe	20/04/12	BU
Allos Therapeutics, Inc. : Spectrum Pharmaceuticals Commences Tender Offer for All Outstanding Shares of Allos Therapeutics	16/04/12	BU
Allos Therapeutics, Inc. : Spectrum Pharmaceuticals to Acquire Allos Therapeutics: Acquisition Expected to Be Accretive on a Cash Basis in Q4 of 2012	05/04/12	BU
Allos Therapeutics, Inc. : Allos Therapeutics Reports Fourth Quarter and Full Year 2011 Financial Results	06/03/12	BU
Allos Therapeutics, Inc. : Allos Therapeutics to Report Fourth Quarter and Full Year 2011 Results on March 6, 2012	21/02/12	BU
Allos Therapeutics, Inc. : Allos Therapeutics Requests Re-Examination of CHMP Opinion on FOLOTYN(R) in PTCL at the European Medicines Agency	30/01/12	PU
Allos Therapeutics, Inc. : Allos Therapeutics Announces Interim Results from Phase 1 Combination Study of FOLOTYN(R) and Bexarotene Demonstrate Activity in Patients with Relapsed or Refractory Cutaneous T-cell Lymphoma	30/01/12	PU
Allos Therapeutics, Inc. : Allos Therapeutics Requests Re-Examination of CHMP Opinion on FOLOTYN® in PTCL at the European Medicines Agency	30/01/12	BU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Allos Therapeutics, Inc.

Actions

US0197771019

Communiqués

Filtres